Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)

  • STATUS
    Recruiting
  • participants needed
    2000
  • sponsor
    Hospital Israelita Albert Einstein
Send
Updated on 16 February 2024
See if I qualify
covid-19
biological factors
SARS
acute respiratory syndrome (sars)

Summary

This is a registry-based cohort study of all adult patients (18 years) with confirmed or suspected SARS-CoV-2 infection.

The main goal is to describe mortality incidence, demographic characteristics, coexisting conditions, treatments, outcomes among SARS-CoV2 infected patients.

A secondary goal is to identify biological factors (OMICS - genomic, proteomic and metabolomics characterization) associated with severity conditions for these patients.

Description

Registry on characteristics and outcomes of hospitalized and non-hospitalized SARS-CoV2 infected patients in Brazil.

Details
Condition Severe Acute Respiratory Syndrome, COVID19
Age 18years - 100years
Treatment Hospital admission, Non-hospitalization procedures
Clinical Study IdentifierNCT04479488
SponsorHospital Israelita Albert Einstein
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Adult patients (18 years)
Confirmed or suspected SARS-CoV2 infection

Exclusion Criteria

Patient who expressed opposition to participation in the study
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

covid-19
biological factors
SARS
acute respiratory syndrome (sars)

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.